- Pnina Peled, the executive chef at MSKCC, was recently featured in a New York Times article.
- Agenus Inc. recently announced it has entered into a research agreement with MSKCC to test Agenus’ cancer vaccine in combination with antibodies that are intended to target specific markers on tumor cells, such as CTLA-4 and PDL-1.
- Dr. Paul Chapman, who led a trial for an experimental drug aimed at melanoma, was recently quoted in a New York Times article about the trial’s promising results.